Your browser doesn't support javascript.
loading
Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy.
Kaufman, Peter A; Toi, Masakazu; Neven, Patrick; Sohn, Joohyuk; Grischke, Eva-Maria; Andre, Valerie; Stoffregen, Clemens; Shekarriz, Sarah; Price, Gregory L; Carter, Gebra Cuyun; Sledge, George W.
Afiliación
  • Kaufman PA; University of Vermont Cancer Center, University of Vermont Medical Center, Burlington, Vermont, USA.
  • Toi M; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Neven P; University Hospitals Leuven, Leuven, Belgium.
  • Sohn J; Yonsei Cancer Center, Seoul, Republic of Korea.
  • Grischke EM; Department of Women's Health, University Hospital Tübingen, Tübingen, Germany.
  • Andre V; Eli Lilly and Company, Paris, France.
  • Stoffregen C; Eli Lilly and Company, Bad Homburg, Germany.
  • Shekarriz S; Eli Lilly and Company, Bad Homburg, Germany.
  • Price GL; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Carter GC; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Sledge GW; Stanford University School of Medicine, Stanford, California, USA.
Oncologist ; 25(2): e243-e251, 2020 02.
Article en En | MEDLINE | ID: mdl-32043763

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias de la Mama Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias de la Mama Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Oncologist Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos